Novartis Pharmaceuticals Corporation - COSENTYX® (secukinumab)

Novartis is a leading global medicines company. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 110,000 people of more than 140 nationalities work at Novartis around the world. Find out more at https://www.novartis.com.


© 2022 Novartis                       9/22                                 208744